Success Metrics

Active Trials
3(75%)

Phase Distribution

Ph not_applicable
1
25%
Ph early_phase_1
2
50%
Ph phase_1
1
25%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
2(50.0%)
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Other(1)

Detailed Status

Recruiting2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 12 (50.0%)
Phase 11 (25.0%)
N/A1 (25.0%)

Trials by Status

recruiting250%
active_not_recruiting125%
unknown125%

Recent Activity

3 active trials
Showing 4 of 4
recruitingearly_phase_1

MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing

NCT05505110
active_not_recruitingearly_phase_1

Vaginal Microbiome Exposure and Immune Responses in C-section Infants

NCT03567707
recruitingphase_1

Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.

NCT03298334
unknownnot_applicable

Effects of Vaginal Seeding on Infants' Body Mass Index and Allergy Risk for Caesarean-delivered Children

NCT03809390

Clinical Trials (4)

Showing 4 of 4 trials
NCT05505110Early Phase 1

MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing

Recruiting
NCT03567707Early Phase 1

Vaginal Microbiome Exposure and Immune Responses in C-section Infants

Active Not Recruiting
NCT03298334Phase 1

Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.

Recruiting
NCT03809390Not Applicable

Effects of Vaginal Seeding on Infants' Body Mass Index and Allergy Risk for Caesarean-delivered Children

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4